Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. 2010

Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
Dept. of Clinical Pharmacology, Univ. of Toyama, Japan.

Maternal insulin resistance is essential for efficient provision of glucose to the fetus. Although elevation of placental hormones is known to relate to the development of insulin resistance, the precise underlying mechanism of maternal insulin resistance is unknown. Therefore, we examined the molecular mechanisms of progesterone causing insulin resistance in 3T3-L1 adipocytes. Progesterone at 10(-4) M, but not 10(-5) M, reduced the amount of IRS-1. As a result, insulin-induced phosphorylation of IRS-1, the association of IRS-1 with p85alpha, and subsequent phosphorylation of Akt1 and -2 was decreased moderately by 10(-4) M progesterone. Subsequently, insulin-induced translocation of GLUT4 to the plasma membrane evaluated by immunostaining on the plasma membrane sheet by confocal laser microscope was also decreased by 10(-4) M progesterone. In contrast, 2-[(3)H]deoxyglucose (2DG) uptake was markedly inhibited by both 10(-5) and 10(-4) M progesterone in a dose-dependent manner. Surprisingly, 2DG uptake elicited by adenovirus-mediated expression of constitutive-active mutant of PI 3-kinase (myr-p110) and Akt (myr-Akt) was suppressed by progesterone. Interestingly, insulin-induced tyrosine phosphorylation of Cbl and activation of TC10 were inhibited by progesterone at 10(-5) M. These results indicate that progesterone is implicated in insulin resistance during pregnancy by inhibiting the PI 3-kinase pathway at the step of 1) IRS-1 expression and 2) distal to Akt and 3) by suppressing the PI 3-kinase-independent pathway of TC10 activation by affecting Cbl phosphorylation.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose

Related Publications

Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
July 2004, Biochemical pharmacology,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
March 2008, FEBS letters,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
July 2018, Obesity (Silver Spring, Md.),
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
January 2002, Journal of cellular biochemistry,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
September 2008, The Journal of endocrinology,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
January 2005, Biochemical and biophysical research communications,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
February 2009, Biochemical and biophysical research communications,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
January 2003, Methods in molecular medicine,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
October 2004, American journal of physiology. Endocrinology and metabolism,
Tsutomu Wada, and Satoko Hori, and Maine Sugiyama, and Eriko Fujisawa, and Tetsuro Nakano, and Hiroshi Tsuneki, and Kiyofumi Nagira, and Shigeru Saito, and Toshiyasu Sasaoka
March 2013, Journal of lifestyle medicine,
Copied contents to your clipboard!